Covid vaccine trial stopped after volunteer shows neurological symptoms | World News - Hindustan Times
close_game
close_game

Covid vaccine trial stopped after volunteer shows neurological symptoms

London | ByAssociated Press | Posted by Niyati Singh
Sep 11, 2020 10:50 PM IST

A woman who received an experimental coronavirus vaccine developed severe neurological symptoms that prompted a pause in testing, a spokesman for drugmaker AstraZeneca said Thursday.

A woman who received an experimental coronavirus vaccine developed severe neurological symptoms that prompted a pause in testing, a spokesman for drugmaker AstraZeneca said Thursday.

It did not provide any details other than to say a single participant had an “unexplained illness.” The vaccine was initially developed by Oxford University after the coronavirus pandemic began this year.(File photo for representation)
It did not provide any details other than to say a single participant had an “unexplained illness.” The vaccine was initially developed by Oxford University after the coronavirus pandemic began this year.(File photo for representation)

The study participant in late-stage testing reported symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, said company spokesman Matthew Kent.

HT launches Crick-it, a one stop destination to catch Cricket, anytime, anywhere. Explore now!

“We don’t know if it is (transverse myelitis),” Kent said. “More tests are being done now as part of the follow-up.” On Tuesday, AstraZeneca said its “standard review process triggered a pause to vaccination to allow review of safety data.”

It did not provide any details other than to say a single participant had an “unexplained illness.” The vaccine was initially developed by Oxford University after the coronavirus pandemic began this year.

Kent said an independent committee was reviewing the study’s safety data before deciding if and when the research could continue.

The study was previously stopped in July for several days after a participant who got the vaccine developed neurological symptoms; it turned out to be an undiagnosed case of multiple sclerosis that was unrelated to the vaccine.

Late last month, AstraZeneca began recruiting 30,000 people in the U.S. for its largest study of the vaccine. It also is testing the vaccine in thousands of people in Britain, and in smaller studies in Brazil and South Africa. Several other Covid-19 vaccine candidates are in development.

Dr. Soumya Swaminathan, the World Health Organization’s chief scientist, said the U.N. health agency wasn’t overly concerned by the pause in the Oxford and AstraZeneca vaccine trial, describing it as “a wake-up call” to the global community about the inevitable ups and downs of medical research.

Temporary holds of large medical studies aren’t unusual, and investigating any serious or unexpected reaction is a mandatory part of safety testing.

AstraZeneca pointed out that it’s possible the problem could be a coincidence; illnesses of all sorts could arise in studies of thousands of people.

Discover the pivotal moments that shaped India's electoral journey on the Eras section of our exclusive Elections product. Access all content absolutely free on the HT App. Download now!

Get Latest World News, along with Latest News from India at Hindustan Times.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Wednesday, April 24, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On